1-10 of 10
Authors: Rebecca Gardner
Save search
Sort by
Journal Article

CTIM-02. PIONEERING QUAD-TARGETING CAR T CELL THERAPY IN PEDIATRIC CNS TUMORS – ANALYSIS FROM THE INITIAL PATIENTS TREATED ON THE FIRST-IN-HUMAN PHASE 1 TRIAL BRAINCHILD-04

PDF
Rebecca Ronsley and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii84, https://doi.org/10.1093/neuonc/noae165.0336
Published: 11 November 2024
Journal Article

TRLS-12. INTRAVENTRICULAR B7-H3 CAR T CELLS FOR DIFFUSE INTRINSIC PONTINE GLIOMA: INTERIM ANALYSIS OF BRAINCHILD-03 ARM C

PDF
Nicholas Vitanza and others
Neuro-Oncology, Volume 25, Issue Supplement_1, June 2023, Pages i81–i82, https://doi.org/10.1093/neuonc/noad073.315
Published: 12 June 2023
Journal Article

IMMU-13. PRECLINICAL EFFICACY OF MULTI-ANTIGEN (HER2/EGFR806/B7-H3/IL13RA2) TARGETING QUAD-CAR T CELLS AGAINST DIFFUSE MIDLINE GLIOMA

PDF
Carrie Myers and others
Neuro-Oncology, Volume 25, Issue Supplement_1, June 2023, Page i52, https://doi.org/10.1093/neuonc/noad073.200
Published: 12 June 2023
Journal Article

LTBK-03. Targeted mass spectrometry of serial CSF and serum specimens from children with diffuse intrinsic pontine glioma treated with intracranial B7-H3 CAR T cells

PDF
Nicholas Vitanza and others
Neuro-Oncology, Volume 24, Issue Supplement_1, June 2022, Page i191, https://doi.org/10.1093/neuonc/noac079.715
Published: 13 June 2022
Journal Article

IMMU-09. Interim analysis from BrainChild-03: Seattle Children’s Locoregional B7-H3 CAR T Cell Trial for Children with Recurrent Central Nervous System Tumors and DIPG

PDF
Nicholas Vitanza and others
Neuro-Oncology, Volume 24, Issue Supplement_1, June 2022, Page i83, https://doi.org/10.1093/neuonc/noac079.302
Published: 03 June 2022
Journal Article

CTIM-27. LOCOREGIONAL B7-H3-SPECIFIC CAR T CELLS FOR CHILDREN AND YOUNG ADULTS WITH DIPG: INTERIM REPORT OF BRAINCHILD-03 ARM C

PDF
Nicholas Vitanza and others
Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Page vi56, https://doi.org/10.1093/neuonc/noab196.219
Published: 12 November 2021
Journal Article

IMMU-11. CLINICAL UPDATES AND CORRELATIVE FINDINGS FROM THE FIRST PATIENT WITH DIPG TREATED WITH INTRACRANIAL CAR T CELLS

PDF
Nicholas Vitanza and others
Neuro-Oncology, Volume 23, Issue Supplement_1, June 2021, Page i29, https://doi.org/10.1093/neuonc/noab090.119
Published: 01 June 2021
Journal Article

IMMU-02. CHIMERIC ANTIGEN RECEPTOR (CAR) T CELL NEUROTOXICITY CORRELATES WITH PRETREATMENT AND ACUTE CSF NEUROFILAMENT LIGHT CHAIN (NFL) LEVELS

PDF
Juliane Gust and others
Neuro-Oncology, Volume 22, Issue Supplement_3, December 2020, Page iii360, https://doi.org/10.1093/neuonc/noaa222.359
Published: 04 December 2020
Journal Article

IMMU-02. LOCOREGIONAL HER2CAR T CELLS FOR PEDIATRIC CENTRAL NERVOUS SYSTEM TUMORS: PRECLINICAL EFFICACY TO TOLERABILITY IN FIRST PATIENT

PDF
Nicholas Vitanza and others
Neuro-Oncology, Volume 21, Issue Supplement_2, April 2019, Page ii93, https://doi.org/10.1093/neuonc/noz036.123
Published: 23 April 2019
Journal Article

IMMU-11. BRAINCHILD PIPELINE: LOCOREGIONAL IMMUNOTHERAPY WITH CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELLS FOR RECURRENT/REFRACTORY CENTRAL NERVOUS SYSTEM TUMORS

PDF
Nicholas Vitanza and others
Neuro-Oncology, Volume 20, Issue suppl_2, June 2018, Pages i100–i101, https://doi.org/10.1093/neuonc/noy059.327
Published: 22 June 2018